Total Payments
$20,608
2024 Payments
$2,065
Companies
31
Transactions
712
Medicare Patients
3,409
Medicare Billing
$551,322
Payment Breakdown by Category
Food & Beverage$20,183 (97.9%)
Other$385.00 (1.9%)
Education$40.11 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,183 | 703 | 97.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $385.00 | 2 | 1.9% |
| Education | $40.11 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $4,006 | 127 | $0 (2024) |
| Novo Nordisk Inc | $2,990 | 163 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,530 | 58 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,589 | 35 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,214 | 52 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,208 | 39 | $0 (2024) |
| Lilly USA, LLC | $1,089 | 41 | $0 (2024) |
| Merck Sharp & Dohme LLC | $841.01 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $717.85 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $559.71 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,065 | 68 | Novo Nordisk Inc ($458.09) |
| 2023 | $1,926 | 75 | AstraZeneca Pharmaceuticals LP ($385.35) |
| 2022 | $1,477 | 72 | Janssen Pharmaceuticals, Inc ($479.51) |
| 2021 | $2,200 | 88 | Janssen Pharmaceuticals, Inc ($606.68) |
| 2020 | $1,579 | 76 | Janssen Pharmaceuticals, Inc ($482.27) |
| 2019 | $3,941 | 122 | Janssen Pharmaceuticals, Inc ($1,049) |
| 2018 | $3,782 | 120 | Janssen Pharmaceuticals, Inc ($711.50) |
| 2017 | $3,638 | 91 | AstraZeneca Pharmaceuticals LP ($638.39) |
All Payment Transactions
712 individual payment records from CMS Open Payments — Page 3 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $129.99 | General |
| Category: Respiratory | ||||||
| 03/22/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/21/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $116.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Cardio-renal | ||||||
| 03/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Diabetes | ||||||
| 03/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $34.33 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Obesity | ||||||
| 02/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Diabetes | ||||||
| 02/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Respiratory | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 01/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: Diabetes | ||||||
| 01/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Diabetes | ||||||
| 01/05/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/15/2023 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Obesity | ||||||
| 12/07/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 808 | 1,717 | $218,365 | $116,434 |
| 2022 | 14 | 714 | 1,768 | $248,245 | $132,172 |
| 2021 | 18 | 1,022 | 2,246 | $286,075 | $161,060 |
| 2020 | 19 | 865 | 2,061 | $284,120 | $141,657 |
Total Patients
3,409
Total Services
7,792
Medicare Billing
$551,322
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 858 | $115,815 | $60,288 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 242 | $42,350 | $25,734 | 60.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 66 | 102 | $12,255 | $7,502 | 61.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 70 | $8,400 | $4,911 | 58.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 22 | $5,060 | $3,496 | 69.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 16 | $5,600 | $2,460 | 43.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 106 | 106 | $3,180 | $2,443 | 76.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 105 | 105 | $3,150 | $2,420 | 76.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 24 | 35 | $4,550 | $1,764 | 38.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 16 | $4,000 | $1,647 | 41.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,400 | $1,375 | 31.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 93 | 109 | $7,085 | $1,310 | 18.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 24 | 25 | $2,520 | $1,084 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 223 | 900 | $121,500 | $62,466 | 51.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 365 | $63,875 | $37,592 | 58.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 70 | 108 | $13,035 | $8,126 | 62.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 85 | $10,200 | $5,340 | 52.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 24 | $8,400 | $4,021 | 47.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 19 | $4,370 | $2,784 | 63.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 39 | 50 | $5,000 | $2,390 | 47.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 19 | 24 | $6,000 | $2,270 | 37.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 32 | 40 | $5,200 | $2,023 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $3,000 | $1,853 | 61.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 30 | $2,550 | $1,344 | 52.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 30 | 30 | $900.00 | $695.19 | 77.2% |
About Dr. Damon Lee, MD
Dr. Damon Lee, MD is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922095256.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Damon Lee, MD has received a total of $20,608 in payments from pharmaceutical and medical device companies, with $2,065 received in 2024. These payments were reported across 712 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($20,183).
As a Medicare-enrolled provider, Lee has provided services to 3,409 Medicare beneficiaries, totaling 7,792 services with total Medicare billing of $551,322. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 10/03/2005
- Last Updated 01/15/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922095256
Products in Payments
- XARELTO (Drug) $3,050
- Ozempic (Drug) $1,502
- ENTRESTO (Drug) $1,104
- JARDIANCE (Drug) $999.32
- INVOKANA (Drug) $956.42
- ELIQUIS (Drug) $869.33
- TRULICITY (Drug) $679.92
- TRELEGY ELLIPTA (Drug) $641.17
- FARXIGA (Drug) $576.08
- Kerendia (Drug) $559.71
- BEVESPI AEROSPHERE (Drug) $505.82
- LifeVest (Device) $441.90
- Rybelsus (Drug) $427.23
- SOLIQUA (Drug) $362.42
- BREZTRI (Drug) $353.65
- AIRSUPRA (Drug) $337.43
- Tresiba (Drug) $335.46
- MOUNJARO (Drug) $327.42
- SYMBICORT (Drug) $289.50
- VERQUVO (Drug) $276.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Internal Medicine $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Internal Medicine $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Internal Medicine $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Internal Medicine $22,968
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620
Internal Medicine $18,620
Dr. Yin-Yin Myint, M.d, M.D
Internal Medicine — Payments: $13,665
Internal Medicine $13,665